Pharvaris NV (PHVS)
19.18
+0.28
(+1.48%)
USD |
NASDAQ |
May 31, 16:00
19.24
+0.06
(+0.31%)
After-Hours: 20:00
Pharvaris Cash from Operations (Quarterly): -26.32M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -26.32M |
| December 31, 2023 | -25.35M |
| September 30, 2023 | -25.57M |
| June 30, 2023 | -22.75M |
| March 31, 2023 | -27.07M |
| December 31, 2022 | -23.74M |
| September 30, 2022 | -13.47M |
| June 30, 2022 | -13.56M |
| March 31, 2022 | -20.06M |
| Date | Value |
|---|---|
| December 31, 2021 | -14.93M |
| September 30, 2021 | -11.26M |
| June 30, 2021 | -14.29M |
| March 31, 2021 | -12.29M |
| December 31, 2020 | -9.832M |
| September 30, 2020 | -8.152M |
| June 30, 2020 | -4.004M |
| March 31, 2020 | -2.566M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-27.07M
Minimum
Mar 2023
-2.566M
Maximum
Mar 2020
-16.19M
Average
-14.29M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| uniQure NV | -60.58M |
| ProQR Therapeutics NV | -16.44M |
| Merus NV | -44.39M |
| argenx SE | -- |
| Pharming Group | -7.647M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0334M |
| Cash from Financing (Quarterly) | 0.8636M |
| Free Cash Flow | -100.10M |
| Free Cash Flow Per Share (Quarterly) | -0.4897 |
| Free Cash Flow Yield | -11.61% |